- 全部删除
您的购物车当前为空
Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc selectively inhibits the binding of a particular monoclonal antibody, 45531, to CCR5.

Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc selectively inhibits the binding of a particular monoclonal antibody, 45531, to CCR5.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 16,900 | 10-14周 | |
| 50 mg | ¥ 22,800 | 10-14周 | |
| 100 mg | ¥ 30,700 | 10-14周 |
Aplaviroc hydrochloride 相关产品
| 产品描述 | Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc selectively inhibits the binding of a particular monoclonal antibody, 45531, to CCR5. |
| 靶点活性 | HIV-1 (Ba-L):0.4 nM (IC50), HIV-1 (MOKW):0.2 nM (IC50), HIV-1 (JRFL):0.1 nM (IC50) |
| 别名 | GW873140A, GW-873140, GW873140, Aplaviroc HCl, AK-602, AK602, AK 602 |
| 分子量 | 614.17 |
| 分子式 | C33H44ClN3O6 |
| CAS No. | 461023-63-2 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容